首页> 外文学位 >A novel mechanism of chemoprevention by sulforaphane: Inhibition of histone deacetylase.
【24h】

A novel mechanism of chemoprevention by sulforaphane: Inhibition of histone deacetylase.

机译:萝卜硫烷化学预防的新机制:组蛋白脱乙酰基酶的抑制。

获取原文
获取原文并翻译 | 示例

摘要

Targeting the epigenome, including the use of histone deacetylase (HDAC) inhibitors, is a novel strategy for cancer chemoprevention. Sulforaphane (SFN), a compound found at high levels in broccoli and broccoli sprouts, is a potent inducer of Phase 2 detoxification enzymes and inhibits tumorigenesis in animal models. SFN also has a marked effect on cell cycle checkpoint controls and cell survival/apoptosis in various cancer cells, through mechanisms that are poorly understood. Based on the structure of known histone deacetylase inhibitors, it was hypothesized that SFN may possess HDAC inhibitory properties. Initial studies confirmed that, indeed, at physiologically-relevant concentrations, SFN inhibited HDAC activity in human colorectal cancer cells, with a concomitant increase in acetylated histones H3 and H4, induction of p21 expression, and increased acetylated histone H4 associated with the P21 promoter. A metabolite of SFN, SFN-Cysteine, was found to be the active HDAC inhibitor. Furthermore, in BPH-1, LnCaP, and PC-3 human prostate epithelial cells, SFN inhibited HDAC activity and increased acetylation of histones. SFN also induced p21 expression, with an increase in acetylated histone H4 associated with the P21 promoter in BPH-1 cells. The downstream effects of HDAC inhibition by SFN included induction of pro-apoptotic proteins and repression of anti-apoptotic proteins, and an increase in multi-caspase activity. Dietary SFN suppressed the growth of human prostate cancer PC-3 xenografts and inhibited HDAC activity in the xenografts, peripheral blood mononuclear cells (PBMC), and prostates. In time-course studies, a single oral dose of SFN induced histone acetylation at 6 and 24 h in mouse colonic mucosa, and long-term dietary SFN treatment increased histone acetylation in the ileum, colon, PBMC, and prostates. Moreover, dietary SFN suppressed intestinal tumorigenesis significantly in Apcmin mice, with an increase in acetylated histones detected in the normal-looking ileum and polyps and polyps from the colon. Overall, the data presented in this thesis support a novel mechanism for chemoprevention by SFN in vivo, through inhibition of histone deacetylase. The findings also imply that SFN will offer significant protection against at least two of the major cancer killers in the US, namely colon and prostate cancer.
机译:靶向表观基因组,包括使用组蛋白脱乙酰基酶(HDAC)抑制剂,是癌症化学预防的一种新策略。萝卜硫素(SFN)是一种在西兰花和西兰花芽中高含量发现的化合物,是2相排毒酶的有效诱导剂,并在动物模型中抑制肿瘤发生。通过尚不了解的机制,SFN对各种癌细胞的细胞周期检查点控制和细胞存活/凋亡也具有显著作用。基于已知的组蛋白脱乙酰基酶抑制剂的结构,假设SFN可能具有HDAC抑制特性。最初的研究证实,实际上,在生理相关浓度下,SFN抑制了人类结直肠癌细胞中的HDAC活性,同时乙酰化组蛋白H3和H4增加,p21表达诱导以及与P21启动子相关的乙酰化组蛋白H4增加。发现SFN的代谢产物SFN-半胱氨酸是活性HDAC抑制剂。此外,在BPH-1,LnCaP和PC-3人前列腺上皮细胞中,SFN抑制HDAC活性并增加组蛋白的乙酰化。 SFN也诱导p21表达,并增加BPH-1细胞中与P21启动子相关的乙酰化组蛋白H4的表达。 SFN抑制HDAC的下游作用包括诱导促凋亡蛋白和抑制抗凋亡蛋白,以及多半胱天冬酶活性的增加。膳食SFN抑制人前列腺癌PC-3异种移植物的生长,并抑制异种移植物,外周血单核细胞(PBMC)和前列腺中的HDAC活性。在时程研究中,SFN的单次口服剂量在小鼠结肠粘膜的6和24 h诱导组蛋白乙酰化,长期饮食SFN治疗增加了回肠,结肠,PBMC和前列腺中的组蛋白乙酰化。此外,日粮SFN在Apcmin小鼠中显着抑制肠道肿瘤发生,在正常回肠,结肠息肉和息肉中检测到乙酰化组蛋白增加。总体而言,本论文提供的数据支持通过抑制组蛋白脱乙酰基酶在体内通过SFN进行化学预防的新机制。该发现还暗示,SFN将针对美国至少两种主要的癌症杀手,即结肠癌和前列腺癌提供有效的保护。

著录项

  • 作者

    Myzak, Melinda C.;

  • 作者单位

    Oregon State University.;

  • 授予单位 Oregon State University.;
  • 学科 Biology Molecular.; Biology Cell.; Health Sciences Oncology.
  • 学位 Ph.D.
  • 年度 2005
  • 页码 206 p.
  • 总页数 206
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分子遗传学;细胞生物学;肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号